Department of Clinical Sciences, Touro University California College of Pharmacy, 1310 Club Drive, Vallejo, CA, 94592, USA.
Department of Clinical Sciences, Touro University California College of Pharmacy, 1310 Club Drive, Vallejo, CA, 94592, USA; Division of Primary Care and Population Health, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Res Social Adm Pharm. 2021 Jul;17(7):1356-1360. doi: 10.1016/j.sapharm.2020.09.015. Epub 2020 Oct 2.
Non-prescription cannabidiol (CBD) products have recently been available in community pharmacies. However, there is only limited data to support its use, placing community pharmacists in a challenging position to provide evidence-based information to patients.
The objective of this study was to assess knowledge, experience, and confidence of non-prescription CBD products among community pharmacists.
A 38-question pen-and-paper survey pertaining to knowledge, experience, and confidence of non-prescription CBD products was administered to community pharmacists in the California Bay Area. Inclusion criteria consisted of registered pharmacists at community pharmacies during regular business hours. Participants were excluded if they were under 18 years old or unwilling to participate.
Of 128 pharmacists, 103 took part and completed the survey (response rate 80.4%). The majority (78.5%) were unable to answer at least 80% of the non-prescription CBD knowledge-based questions. Over 50% have received patient questions and 20.4% recommended non-prescription CBD products in the last 12 months. More than half were "not confident" answering questions about non-prescription CBD products, and 14.5% received formal training on the topic.
Despite patients commonly asking about non-prescription CBD products, the majority of pharmacists lack clinical knowledge and confidence on the topic. There is a need to provide formal training and educational resources on non-prescription CBD products.
非处方大麻二酚（CBD）产品最近已在社区药店中出售。然而，只有有限的数据支持其使用，这使得社区药剂师难以向患者提供基于证据的信息。
本研究旨在评估社区药剂师对非处方 CBD 产品的知识、经验和信心。
对加利福尼亚湾区社区药剂师进行了一项 38 个问题的纸笔调查，涉及非处方 CBD 产品的知识、经验和信心。纳入标准包括在社区药店营业时间内注册的药剂师。如果参与者未满 18 岁或不愿意参加，则将其排除在外。
在 128 名药剂师中，有 103 人参加并完成了调查（应答率为 80.4%）。大多数（78.5%）至少无法回答 80%的非处方 CBD 基于知识的问题。超过 50%的人在过去 12 个月中收到过患者关于非处方 CBD 产品的问题，20.4%的人推荐了非处方 CBD 产品。超过一半的人“不自信”回答非处方 CBD 产品的问题，14.5%的人接受过该主题的正式培训。
尽管患者经常询问非处方 CBD 产品，但大多数药剂师缺乏该主题的临床知识和信心。需要提供有关非处方 CBD 产品的正式培训和教育资源。
